Analysts name 2 ASX dividend shares to buy

These dividend shares could be in the buy zone…

Are you looking for income options for your portfolio? If you are, then you might want to consider the ASX shares listed below.

Here's why they could top options for income investors:

A man takes his dividend and leaps for joy.

Image source: Getty Images

Accent Group Ltd (ASX: AX1)

Accent could be a dividend share to buy. It is a retail group that owns a collection of popular footwear-focused store brands including HYPEDC, Platypus, and The Athlete's Foot.

These brands have carved out a very strong position in the leisure footwear market for Accent, which, together with its expanding store network, has underpinned strong earnings growth in recent years.

The team at Bell Potter appear confident this strong form will continue over the long term. Though, it acknowledges that lockdowns will weigh on its performance in FY 2022. Bell Potter currently has a buy rating and $2.90 price target on its shares.

It is also forecasting fully franked dividends per share of 9.3 cents in FY 2022 and 13.3 cents in FY 2023. Based on the latest Accent share price of $2.46, this represents yields of 3.8% and 5.4%, respectively.

Commonwealth Bank of Australia (ASX: CBA)

Another ASX dividend share that Bell Potter is a fan of is Australia's largest bank. Its analysts currently have a buy rating and $118.00 price target on its shares.

Bell Potter likes CBA due to its strong position as the leader in home lending and retail deposits. It also notes that it has a very strong balance sheet with significant surplus capital. In addition, the broker sees opportunities to add value via SME banking, wealth management, and selective Asian expansion.

Its team are forecasting fully franked dividends per share of $4.06 in FY 2022 and $4.27 in FY 2023. Based on the current CBA share price of $105.10, this will mean yields of 3.9% and 4.2%, respectively.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Accent Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

Person holding Australian dollar notes, symbolising dividends.
Dividend Investing

75% of my dividends come from these 4 ASX shares (and I want to buy more)

I rate these stocks as top options for dividend income.

Read more »

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

Why the Paladin Energy share price "doesn't make sense"

This uranium stock could be set for a major re-rating.

Read more »

Girl with painted hands.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a remarkably positive end to the trading week.

Read more »

Two miners standing together.
Broker Notes

3 ASX 200 mining shares to buy with 41% to 79% upside ahead: broker

The green energy transition and other factors are providing strong growth drivers for mining.

Read more »

Happy miner with his arms folded.
Broker Notes

Buy, hold, sell: Paladin Energy, Fortescue, Rio Tinto shares

Let's take a look at some new ratings from Morgans.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

9 ASX 200 shares experts are backing for growth amid market weakness

Brokers retained a positive view on BHP, CSL, Telstra, Xero, and other shares this week. 

Read more »

One large yellow sphere on one side of a white seesaw, with a small yellow sphere on the other side.
Opinions

I investigated 3 ASX shares that have fallen sharply. Are they bargains or value traps?

I've given my verdict on three depressed high-profile stocks.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

This ASX biotech could rise 40% or 750%, depending on who you ask

A poor quarter has reduced expectations, but there's still plenty of upside.

Read more »